The clinical trial of the future

The industry is approaching a new age of trials that are streamlined, connected and more engaged with the patient – but only if pharma can embrace the changes
The hard sell

With the 2016 PharmaTimes Sales Awards fast approaching, we look at the skills needed by the modern sales rep to survive
On target?

Precision medicine is fundamentally changing how we treat patients, but is it too early to get excited about this burgeoning area?
International Clinical Researcher of the Year 2017: Stage 2 Challenges available

Competition organiser PharmaTimes Media is delighted to announce that the Stage 2 challenges are now available online for the top achievers in the MCQ.

News

View all

NHS announces new mental health pilot programme

Six pilot sites will drive the design of new mental health services for young people

30th September 2016

Genentech in $910 million cancer licensing deal

Company buys rights to experimental pan-RAF inhibitor

30th September 2016

NICE rejects Lilly’s Portrazza, but backs Bayer’s Xofigo and Amgen’s Imlygic

Cost regulators for the NHS in England and Wales have published final guidelines turning down the use of Eli Lilly's Portrazza to treat lung cancer, but backing Bayer's Xofigo for prostate cancer and Amgen's Imlygic for melanoma.

30th September 2016

International Clinical Researcher of the Year 2017: Stage 2 Challenges available

Competition organiser PharmaTimes Media is delighted to announce that the Stage 2 challenges are now available online for the top achievers in the MCQ.

29th September 2016

Common painkillers could increase heart failure risk, study finds

BMJ study shows NSAIDs increase risk by 19 percent in elderly patients

29th September 2016

Web Exclusives

View all

Making precision medicine work

Cancer Research UK's head of precision medicine on how the charity is preparing the NHS for this paradigm shift in treatment

Inclusion criteria

With new research showing that pharma senior teams are less diverse than comparable industries, companies could do more to instil a culture of inclusion

Now it's personal

Putting the right tools in patients' hands could personalise treatment and improve health across the board

Industry roundup – 21 July

Biobank banks genes of long-lived Sardinians; stem cell therapies face commercial challenges; VBI moves forward with Zika Vaccine

Magazine

View more from the latest edition

The hard sell

With the 2016 PharmaTimes Sales Awards fast approaching, we look at the skills needed by the modern sales rep to survive

The clinical trial of the future

The industry is approaching a new age of trials that are streamlined, connected and more engaged with the patient – but only if pharma can embrace the changes

On target?

Precision medicine is fundamentally changing how we treat patients, but is it too early to get excited about this burgeoning area?

Higher education

Pharma-sponsored medical education has always been about much more than just education, yet with greater transparency, changing learning styles and increased influence of expert patients, what does the future hold for pharma's wider interactions with healthcare professionals?